Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 713,800 shares at $2.10 ($1.5M) on 2026-04-02, disclosed to the SEC on 2026-04-03.
Open-market purchase of $1.5M ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |
| ANVS | BUY | 2025-11-18 | $32K | — | Filing → |